Treatment of pulmonary hypertension secondary to connective tissue diseases.
作者信息
Sanchez O, Humbert M, Sitbon O, Simonneau G
机构信息
Service de Pneumologie et Réanimation Respiratoire, UPRES Maladies Vasculaires Pulmonaires, Hôpital Antoine Béclère, Clamart, France.
出版信息
Thorax. 1999 Mar;54(3):273-7. doi: 10.1136/thx.54.3.273.
Abstract
摘要
相似文献
1
Treatment of pulmonary hypertension secondary to connective tissue diseases.结缔组织病继发肺动脉高压的治疗。
Thorax. 1999 Mar;54(3):273-7. doi: 10.1136/thx.54.3.273.
2
Recommendations on the management of pulmonary hypertension in clinical practice.临床实践中肺动脉高压管理的推荐意见。
Heart. 2001 Sep;86 Suppl 1(Suppl 1):I1-13.
3
Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part II: Secondary pulmonary hypertension.
Angiology. 1994 Sep;45(9):755-61. doi: 10.1177/000331979404500902.
4
Pulmonary Hypertension Complicating Connective Tissue Disease.结缔组织病相关的肺动脉高压
Semin Respir Crit Care Med. 2017 Oct;38(5):619-635. doi: 10.1055/s-0037-1606203. Epub 2017 Oct 15.
5
[Therapy of primary pulmonary hypertension].
Dtsch Med Wochenschr. 1993 Dec 10;118(49):1809-13. doi: 10.1055/s-2007-1024183.
6
Pulmonary hypertension and chronic cor pulmonale.肺动脉高压与慢性肺源性心脏病。
Heart Dis Stroke. 1993 Jul-Aug;2(4):335-41.
7
Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects.特发性肺动脉高压与结缔组织病相关肺动脉高压：一篇关注独特临床方面的综述。
Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12876. Epub 2017 Dec 28.
8
Recognition and management of pulmonary hypertension.肺动脉高压的识别与管理。
Drugs. 1998 Dec;56(6):989-1007. doi: 10.2165/00003495-199856060-00004.
9
[Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].[在合并结缔组织病的肺动脉高压患者中通过急性血管扩张试验比较腺苷与伊洛前列素]
Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2099-102.
10
Pulmonary hypertension associated with connective tissue disease.与结缔组织病相关的肺动脉高压。
Prog Cardiovasc Dis. 2002 Nov-Dec;45(3):225-34. doi: 10.1053/pcad.2002.129975.
引用本文的文献
1
Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.系统性红斑狼疮中肺动脉高压的患病率：一项荟萃分析。
Ir J Med Sci. 2018 Aug;187(3):723-730. doi: 10.1007/s11845-017-1727-4. Epub 2017 Dec 18.
2
Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.地塞米松诱导肺动脉平滑肌细胞凋亡。
Respir Res. 2015 Sep 18;16(1):114. doi: 10.1186/s12931-015-0262-y.
3
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.特发性与结缔组织病相关肺动脉高压的治疗反应比较。
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1111-7. doi: 10.1164/rccm.201507-1456OC.
4
Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.结缔组织病相关肺动脉高压的不良事件。
Arthritis Rheumatol. 2015 Sep;67(9):2457-65. doi: 10.1002/art.39220.
5
Pulmonary Arterial Hypertension in Patients with Primary Sjögren's Syndrome.原发性干燥综合征患者的肺动脉高压
Autoimmune Dis. 2014;2014:710401. doi: 10.1155/2014/710401. Epub 2014 Jan 9.
6
Life-threatening complications of adult-onset Still's disease.成人斯蒂尔病的危及生命的并发症。
Clin Rheumatol. 2014 Mar;33(3):305-14. doi: 10.1007/s10067-014-2487-4. Epub 2014 Jan 17.
7
Severe Pulmonary Hypertension in Primary Sjögren's Syndrome.原发性干燥综合征相关肺动脉高压
Korean Circ J. 2013 Jul;43(7):504-7. doi: 10.4070/kcj.2013.43.7.504. Epub 2013 Jul 31.
8
9
Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.风湿性疾病相关肺动脉高压：流行病学与发病机制。
Rheumatol Int. 2013 Jul;33(7):1655-67. doi: 10.1007/s00296-012-2659-y. Epub 2013 Jan 19.
10
Pulmonary hypertension in parenchymal lung disease.实质性肺疾病中的肺动脉高压。
Pulm Med. 2012;2012:684781. doi: 10.1155/2012/684781. Epub 2012 Oct 10.
本文引用的文献
1
PULMONARY VASCULAR LESIONS IN SYSTEMIC SCLERODERMA.
Dis Chest. 1963 Oct;44:374-9. doi: 10.1378/chest.44.4.374.
2
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.吸入一氧化氮作为一种筛查剂，用于在原发性肺动脉高压中安全识别对口服钙通道阻滞剂有反应者。
Eur Respir J. 1998 Aug;12(2):265-70. doi: 10.1183/09031936.98.12020265.
3
Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.原发性肺动脉高压患者长期使用依前列醇（前列环素）治疗可降低肺血管阻力。
N Engl J Med. 1998 Jan 29;338(5):273-7. doi: 10.1056/NEJM199801293380501.
4
Primary pulmonary hypertension.原发性肺动脉高压
N Engl J Med. 1997 Jan 9;336(2):111-7. doi: 10.1056/NEJM199701093360207.
5
a 49-year-old woman with dyspnoea, palpitations and syncope.
Int J Cardiol. 1996 Jul 5;55(1):67-78. doi: 10.1016/0167-5273(96)02658-7.
6
Systemic lupus erythematosus and pulmonary hypertension during pregnancy: report of a case fatality.妊娠期间的系统性红斑狼疮与肺动脉高压：一例死亡报告。
Can J Cardiol. 1996 Aug;12(8):753-6.
7
Improvement of severe pulmonary hypertension in a patient with SLE.系统性红斑狼疮患者严重肺动脉高压的改善
Ann Rheum Dis. 1996 Aug;55(8):561-2. doi: 10.1136/ard.55.8.561.
8
Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension.
Circulation. 1996 Aug 1;94(3):477-82. doi: 10.1161/01.cir.94.3.477.
9
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.持续静脉输注依前列醇（前列环素）与常规疗法治疗原发性肺动脉高压的比较。
N Engl J Med. 1996 Feb 1;334(5):296-301. doi: 10.1056/NEJM199602013340504.
10
Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature.
Hum Pathol. 1993 Feb;24(2):199-205. doi: 10.1016/0046-8177(93)90301-v.
Zotero 插件